Gastric Bypass Resolves Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Low-BMI Patients: A Prospective Cohort Study

Metabolic dysfunction-associated fatty liver disease (MAFLD) reflects the multifactorial pathogenesis of fatty liver disease in metabolically sick patients. The effects of metabolic surgery on MAFLD have not been investigated. This study assesses the impact of Roux-en-Y gastric bypass (RYGB) on MAFL...

Descripción completa

Detalles Bibliográficos
Autores principales: Billeter, Adrian T., Scheurlen, Katharina M., Israel, Barbara, Straub, Beate K., Schirmacher, Peter, Kopf, Stefan, Nawroth, Peter P., Müller-Stich, Beat P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
ESA Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534054/
https://www.ncbi.nlm.nih.gov/pubmed/35880762
http://dx.doi.org/10.1097/SLA.0000000000005631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534054/
https://www.ncbi.nlm.nih.gov/pubmed/35880762
http://dx.doi.org/10.1097/SLA.0000000000005631

Ejemplares similares